Abstract:New findings: What is the topic of this review? Remote ischaemic preconditioning (RIPC) and hypoxic preconditioning as novel therapeutic approaches for cardiac and neuroprotection. What advances does it highlight? There is improved understanding of mechanisms and signalling pathways associated with ischaemic and hypoxic preconditioning, and potential pitfalls with application of these therapies to clinical trials have been identified. Novel adaptations of preconditioning paradigms have also been developed, including intermittent hypoxia training, RIPC training and RIPC-exercise, extending their utility to chronic settings. Abstract: Myocardial infarction and stroke remain leading causes of death worldwide, despite extensive resources directed towards developing effective treatments. In this Symposium Report we highlight the potential applications of intermittent ischaemic and hypoxic conditioning protocols to combat the deleterious consequences of heart and brain ischaemia. Insights into mechanisms underlying the protective effects of intermittent hypoxia training are discussed, including the activation of hypoxia-inducible factor-1 and Nrf2 transcription factors, synthesis of antioxidant and ATP-generating enzymes, and a shift in microglia from pro- to anti-inflammatory phenotypes. Although there is little argument regarding the efficacy of remote ischaemic preconditioning (RIPC) in pre-clinical models, this strategy has not consistently translated into the clinical arena. This lack of translation may be related to the patient populations targeted thus far, and the anaesthetic regimen used in two of the major RIPC clinical trials. Additionally, we do not fully understand the mechanism through which RIPC protects the vital organs, and co-morbidities (e.g. hypercholesterolemia, diabetes) may interfere with its efficacy. Finally, novel adaptations have been made to extend RIPC to more chronic settings. One adaptation is RIPC-exercise (RIPC-X), an innovative paradigm that applies cyclical RIPC to blood flow restriction exercise (BFRE). Recent findings suggest that this novel exercise modality attenuates the exaggerated haemodynamic responses that may limit the use of conventional BFRE in some clinical settings. Collectively, intermittent ischaemic and hypoxic conditioning paradigms remain an exciting frontier for the protection against ischaemic injuries.

Review Cerebral Ischemic Tolerance and Preconditioning: Methods, Mechanisms, Clinical Applications, and Challenges

Cerebral Ischemia/Reperfusion Injury and Pharmacologic Preconditioning as a Means to Reduce Stroke-induced Inflammation and Damage

Cerebral Conditioning: Mechanisms and Potential Clinical Implications

Preconditioned Stem Cells: A Promising Strategy for Cell-Based Ischemic Stroke Therapy

Advances in intervention methods and brain protection mechanisms of in situ and remote ischemic postconditioning

Postconditioning-Induced Neuroprotection, Mechanisms and Applications in Cerebral Ischemia

Ischaemic and hypoxic conditioning: potential for protection of vital organs

Stroke Preconditioning To Identify Endogenous Protective Or Regenerative Mechanisms

Metabolic Reprogramming: Strategy for Ischemic Stroke Treatment by Ischemic Preconditioning

Insight Into the Mechanism of Exercise Preconditioning in Ischemic Stroke

Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation

Abstract W P109: Nitrosative Stress Preconditioning Ameliorated Neurovascular Injury in Stroke

Remote ischemic conditioning for stroke: clinical data, challenges, and future directions

Ameliorating Effects of Traditional Chinese Medicine Preparation, Chinese Materia Medica and Active Compounds on Ischemia/reperfusion-Induced Cerebral Microcirculatory Disturbances and Neuron Damage.

Beyond Pharmacology: The Biological Mechanisms of Remote Ischemic Conditioning in Cerebrovascular Disease

The neuroprotective mechanism of brain ischemic preconditioning

Ischemic Post-Conditioning: A Feasible Preventive Method for Cerebral Hyperperfusion Syndrome Secondary to Revascularization

Research progress on the mechanism of action and clinical application of remote ischemic post-conditioning for acute ischemic stroke

The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities

Requirement for preclinical prioritization of neuroprotective strategies in stroke: Incorporation of preconditioning

A Review of Future Therapies